MedTrace Logo

Surgical and Refractive Outcomes of Combined Glaucoma Surgery

NCT04335825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2020-04-06

No results posted yet for this study

Summary

The aim of the study is to examine surgical and refractive outcomes of glaucoma combined surgery in six months period of follow up

Conditions

Interventions

PROCEDURE

phacotrabeculectomy

combined antiglaucoma procedure: trabeculectomy with phacoemulsification

PROCEDURE

ExPress antiglaucoma surgery combined with phacoemulsification

combined antiglaucoma procedure: ExPress device implantation with phacoemulsification

Sponsors & Collaborators

  • Medical University of Bialystok

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2019-01-01
Completion
2019-12-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04335825 on ClinicalTrials.gov